These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31903176)

  • 41. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correction: Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.
    Lu HC; Eulo V; Apicelli AJ; Pekmezci M; Tao Y; Luo J; Hirbe AC; Dahiya S
    Oncotarget; 2021 Nov; 12(24):2435-2436. PubMed ID: 34853665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correction: Upregulation of microRNA-125b by G-CSF promotes metastasis in colorectal cancer.
    Zhang X; Ma X; An H; Xu C; Cao W; Yuan W; Ma J
    Oncotarget; 2020 Jan; 11(1):115. PubMed ID: 32002128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correction: Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation
    Lee JW; Ryu YK; Ji YH; Kang JH; Moon EY
    Oncotarget; 2018 Dec; 9(101):37608-37609. PubMed ID: 30680073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma.
    Bharadwaj U; Eckols TK; Xu X; Kasembeli MM; Chen Y; Adachi M; Song Y; Mo Q; Lai SY; Tweardy DJ
    Oncotarget; 2019 Feb; 10(16):1603. PubMed ID: 30899429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma.
    Wang M; Gao H; Qu H; Li J; Liu K; Han Z
    Pharmacol Rep; 2018 Oct; 70(5):963-971. PubMed ID: 30107346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correction: LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics.
    Yao Q; An Y; Hou W; Cao YN; Yao MF; Ma NN; Hou L; Zhang H; Liu HJ; Zhang B
    Oncotarget; 2020 Aug; 11(32):3102. PubMed ID: 32850013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction: Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies.
    Ma F; Dai L; Wang Z; Zhou L; Niu Y; Jiang N
    Oncotarget; 2018 Jun; 9(49):29285. PubMed ID: 30018753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
    Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
    Oncotarget; 2018 Jul; 9(56):30937. PubMed ID: 30112120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correction: Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma).
    Xiong Y; Zhao Q; Li Z; Wang S; Guo H; Liu Z; Huang T
    Oncotarget; 2018 Mar; 9(22):16273. PubMed ID: 29664476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correction: Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.
    Ouyang Z; Guo X; Chen X; Liu B; Zhang Q; Yin Z; Zhai Z; Qu X; Liu X; Peng D; Shen Y; Liu T; Zhang Q
    Oncotarget; 2019 Oct; 10(58):6283-6284. PubMed ID: 31692899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells.
    Kakar SS; Parte S; Carter K; Joshua IG; Worth C; Rameshwar P; Ratajczak MZ
    Oncotarget; 2020 Aug; 11(32):3103-3104. PubMed ID: 32850014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.
    Ohmoto A; Suzuki M; Takai E; Rokutan H; Fujiwara Y; Morizane C; Yanagihara K; Shibata T; Yachida S
    Oncotarget; 2019 Sep; 10(52):5494. PubMed ID: 31534635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.
    Hu J; Song C; Duan B; Zhang X; Li D; Zhu L; Gao H
    Oncotarget; 2018 Jul; 9(58):31311. PubMed ID: 30131857
    [TBL] [Abstract][Full Text]